Skip to main content
. 2020 Nov 2;106(7):674–679. doi: 10.1136/archdischild-2020-319040

Figure 5.

Figure 5

Median duration from diagnosis to first HSCT treatment by year interval for individuals with severe MPS I receiving HSCT as primary therapy. Global distribution is shown. HSCT, haematopoietic stem cell transplants; MPS I, mucopolysaccharidosis type I.